Phase II study of gemcitabine in ovarian cancerVON MINCKWITZ, G; BAUKNECHT, T; VISSEREN-GRUL, C. M et al.Annals of oncology. 1999, Vol 10, Num 7, pp 853-855, issn 0923-7534Article

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer : Results of a large, randomized, multinational, multicenter, phase III studyVON DER MAASE, H; HANSEN, S. W; KERBRAT, P et al.Journal of clinical oncology. 2000, Vol 18, Num 17, pp 3068-3077, issn 0732-183XArticle